News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

NeoGenomics, Inc. (NGNM.OB) Reports Record Revenue Of $18.3 Million, Adjusted EBITDA Of $2.7 Million And Net Income Of $0.02 Per Share For The Fourth Quarter 2013


2/19/2014 7:54:39 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool 

newsletter today!

FT. MEYERS, Fla., Feb. 19, 2014 /PRNewswire/ -- NeoGenomics, Inc. (NASDAQ: NEO), a leading provider of cancer-focused genetic testing services today reported its results for the fourth quarter and full year of 2013.

Fourth Quarter 2013 Highlights:

-- Revenue growth of 23%

Help employers find you! Check out all the jobs and post your resume.


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES